- Home
- BYAH vs GLMD Comparison
BYAH vs GLMD Comparison
Compare BYAH & GLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BYAH | GLMD |
|---|---|---|
| Founded | 2016 | 2000 |
| Country | China | Israel |
| Employees | 41 | N/A |
| Industry | Package Goods/Cosmetics | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.8M | 4.4M |
| IPO Year | N/A | 2013 |
Fundamental Metrics
Financial Performance| Metric | BYAH | GLMD |
|---|---|---|
| Price | $1.15 | $0.65 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 599.0K | 48.3K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.05 | $0.50 |
| 52 Week High | $2.77 | $3.50 |
Technical Indicators
Market Signals| Indicator | BYAH | GLMD |
|---|---|---|
| Relative Strength Index (RSI) | 53.10 | 47.61 |
| Support Level | $0.14 | $0.50 |
| Resistance Level | $2.77 | $0.69 |
| Average True Range (ATR) | 0.15 | 0.05 |
| MACD | -0.09 | 0.01 |
| Stochastic Oscillator | 7.65 | 61.73 |
Price Performance
Historical ComparisonAbout BYAH Park Ha Biological Technology Co. Ltd. Ordinary Shares
Park Ha Biological Technology Co Ltd is engaged in developing its private skincare label, direct skincare products sales and franchise alliances promotions. Its Park Ha brand focuses on providing solutions for problematic skin. The company's Operating Subsidiaries provide skincare and cosmetic products under its brand, Park Ha in China. Its Operating Subsidiaries develop its proprietary beauty products and offer complimentary after-sales beauty services in its physical stores.
About GLMD Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of NASH and fibrosis. The company is currently seeking to advance the development of Aramchol for oncological indications outside of NASH and fibrosis.